Clinical trial NCT00381979: Supportive Expressive Therapy for Depressed and Anxious Adolescents
Official title: Supportive Expressive Therapy for Depressed and Anxious Adolescents
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Depression
Anxiety
Keywords: Depression
Anxiety
Adolescents
Treatment
Supportive Expressive Therapy
Lead sponsor: Centre for Addiction and Mental Health
Sponsor class: OTHER
First posted: 2006-09-28
Enrollment: 20
Sex: ALL
Minimum age (years): 15
Maximum age (years): 24
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.

Detailed description: Supportive Expressive Therapy (SET; a 16 session manualized form of psychodynamic therapy) has been well utilized with adult clients. To date, there is no known systematic study into the benefit of this method of therapy with adolescents who are depressed and/or anxious. It is thought that SET would be useful for this population as it is similar in principle to Interpersonal Relationship Therapy (IPT), which has been shown to be effective for use with depressed adults and youth. Both IPT and SET help clients explore the role they play within challenging relationships in their lives. SET, however, allows for the exploration of more relationships within the adolescents' circle. Moreover, SET explores the adolescents' perceptions of themselves, others, and their wish in relationships. Further, the SET method is more easily individualized in that it affords greater flexibility in design and possibility for change over time. Accordingly, the purpose of this study is to explore the feasibility of utilizing this method of therapy with adolescents who are depressed and anxious. We will be exploring the effectiveness of SET through the resolution of depressed and/or anxious adolescents' conflictual relationships thereby reducing their symptomatology.

Eligibility criteria: Inclusion Criteria:

* 15-24 year old, male \& female adolescents, primary diagnosis of depression or anxiety disorder.
* Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy.
* Medication dose needs to be stable for 4-6 weeks prior to starting therapy.

Exclusion Criteria:

* Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder.
* Clients who are not fluent in English.

Primary outcomes:
measure: BDI
timeFrame: pre and post
measure: MASC
timeFrame: pre and post
measure: Measures collected at pre, post, and follow-up
timeFrame: pre and post
Secondary outcomes:
measure: YSR
timeFrame: pre and post
measure: CBCL
timeFrame: pre and post
measure: FAM
timeFrame: pre and post
measure: CRI
timeFrame: pre and post
measure: SSRS
timeFrame: pre and post
measure: Measures collected at pre, post, and follow-up
timeFrame: pre and post
Other outcomes:
Locations:
city: Toronto
country: Canada
facility: Centre for Addiction and Mental Health
state: Ontario
Study officials:
References: